Literature DB >> 12859977

Rabbit CYP4B1 engineered for high-level expression in Escherichia coli: ligand stabilization and processing of the N-terminus and heme prosthetic group.

Matthew J Cheesman1, Brian R Baer, Yi-Min Zheng, Elizabeth M J Gillam, Allan E Rettie.   

Abstract

Modifications at the N-terminus of the rabbit CYP4B1 gene resulted in expression levels in Escherichia coli of up to 660 nmol/L. Solubilization of the enzyme from bacterial membranes led to substantial conversion to cytochrome P420 unless alpha-naphthoflavone was added as a stabilizing ligand. Mass spectrometry analysis and Edman sequencing of purified enzyme preparations revealed differential N-terminal post-translational processing of the various constructs expressed. Notably, bacterial expression of CYP4B1 produced a holoenzyme with >98.5% of its heme prosthetic group covalently linked to the protein backbone. The near fully covalently linked hemoproteins exhibited similar rates and regioselectivities of lauric acid hydroxylation to that observed previously for the partially heme processed enzyme expressed in insect cells. These studies shed new light on the consequences of covalent heme processing in CYP4B1 and provide a facile system for future mechanistic and structural studies with the enzyme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12859977     DOI: 10.1016/s0003-9861(03)00278-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  21 in total

1.  CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant.

Authors:  Mariko Nakano; Edward J Kelly; Constanze Wiek; Helmut Hanenberg; Allan E Rettie
Journal:  Mol Pharmacol       Date:  2012-07-06       Impact factor: 4.436

2.  Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes.

Authors:  Eric A Evangelista; Rüdiger Kaspera; Nahush A Mokadam; J P Jones; Rheem A Totah
Journal:  Drug Metab Dispos       Date:  2013-09-10       Impact factor: 3.922

3.  CYP2C9 genotype-dependent effects on in vitro drug-drug interactions: switching of benzbromarone effect from inhibition to activation in the CYP2C9.3 variant.

Authors:  Matthew A Hummel; Charles W Locuson; Peter M Gannett; Dan A Rock; Carrie M Mosher; Allan E Rettie; Timothy S Tracy
Journal:  Mol Pharmacol       Date:  2005-06-13       Impact factor: 4.436

4.  Noncovalent interactions dominate dynamic heme distortion in cytochrome P450 4B1.

Authors:  Gareth K Jennings; Mei-Hui Hsu; Lisa S Shock; Eric F Johnson; John C Hackett
Journal:  J Biol Chem       Date:  2018-06-01       Impact factor: 5.157

5.  Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.

Authors:  Rüdiger Kaspera; Suresh B Naraharisetti; Eric A Evangelista; Kristin D Marciante; Bruce M Psaty; Rheem A Totah
Journal:  Biochem Pharmacol       Date:  2011-06-24       Impact factor: 5.858

6.  Ligand characterization of CYP4B1 isoforms modified for high-level expression in Escherichia coli and HepG2 cells.

Authors:  Katharina Roellecke; Vera D Jäger; Veselin H Gyurov; John P Kowalski; Stephanie Mielke; Allan E Rettie; Helmut Hanenberg; Constanze Wiek; Marco Girhard
Journal:  Protein Eng Des Sel       Date:  2017-03-01       Impact factor: 1.650

7.  Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People.

Authors:  Matthew G McDonald; Lindsay M Henderson; Sutapa Ray; Catherine K Yeung; Amanda L Johnson; John P Kowalski; Helmut Hanenberg; Constanze Wiek; Kenneth E Thummel; Allan E Rettie
Journal:  J Pharmacol Exp Ther       Date:  2020-05-18       Impact factor: 4.030

8.  Intramolecular heme ligation of the cytochrome P450 2C9 R108H mutant demonstrates pronounced conformational flexibility of the B-C loop region: implications for substrate binding.

Authors:  Arthur G Roberts; Matthew J Cheesman; Andrew Primak; Michael K Bowman; William M Atkins; Allan E Rettie
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

9.  Glutamine-451 Confers Sensitivity to Oxidative Inhibition and Heme-Thiolate Sulfenylation of Cytochrome P450 4B1.

Authors:  Matthew E Albertolle; Hyun D Song; Clayton J Wilkey; Jere P Segrest; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2019-02-11       Impact factor: 3.739

10.  Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.

Authors:  Helen E Smith; J P Jones; Thomas F Kalhorn; Federico M Farin; Patricia L Stapleton; Connie L Davis; James D Perkins; David K Blough; Mary F Hebert; Kenneth E Thummel; Rheem A Totah
Journal:  Pharmacogenet Genomics       Date:  2008-11       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.